Evaluation of humoral immune response induced by a supplemental dose of inactivated poliovirus vaccine (IPV) administered intradermally or intramuscularly versus a dose of monovalent type 1 oral poliovirus vaccine
Completed
- Conditions
- PoliomyelitisInfections and InfestationsOther viral encephalitis, not elsewhere classified
- Registration Number
- ISRCTN90744784
- Lead Sponsor
- Panacea Biotec Limited (India)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. Healthy children in the target group (6 - 9 months at baseline, either sex)
2. Resident in Moradabad district, Uttar Pradesh, India
Exclusion Criteria
Children with chronic illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method